These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 9608883)
1. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs. van Vlijmen BJ; Pearce NJ; Bergö M; Staels B; Yates JW; Gribble AD; Bond BC; Hofker MH; Havekes LM; Groot PH Arzneimittelforschung; 1998 Apr; 48(4):396-402. PubMed ID: 9608883 [TBL] [Abstract][Full Text] [Related]
2. Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice. van Vlijmen BJ; van 't Hof HB; Mol MJ; van der Boom H; van der Zee A; Frants RR; Hofker MH; Havekes LM J Clin Invest; 1996 Mar; 97(5):1184-92. PubMed ID: 8636429 [TBL] [Abstract][Full Text] [Related]
3. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. van Vlijmen BJ; van den Maagdenberg AM; Gijbels MJ; van der Boom H; HogenEsch H; Frants RR; Hofker MH; Havekes LM J Clin Invest; 1994 Apr; 93(4):1403-10. PubMed ID: 8163645 [TBL] [Abstract][Full Text] [Related]
4. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia. Nikkilä EA; Ylikahri R; Huttunen JK Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608 [TBL] [Abstract][Full Text] [Related]
5. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice. Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130 [TBL] [Abstract][Full Text] [Related]
6. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo. Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467 [TBL] [Abstract][Full Text] [Related]
7. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice. Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207 [TBL] [Abstract][Full Text] [Related]
8. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B. Shimano H; Yamada N; Katsuki M; Yamamoto K; Gotoda T; Harada K; Shimada M; Yazaki Y J Clin Invest; 1992 Nov; 90(5):2084-91. PubMed ID: 1430232 [TBL] [Abstract][Full Text] [Related]
9. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice. van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886 [TBL] [Abstract][Full Text] [Related]
11. Ritonavir impairs lipoprotein lipase-mediated lipolysis and decreases uptake of fatty acids in adipose tissue. den Boer MA; Berbée JF; Reiss P; van der Valk M; Voshol PJ; Kuipers F; Havekes LM; Rensen PC; Romijn JA Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):124-9. PubMed ID: 16269669 [TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice. Delsing DJ; Post SM; Groenendijk M; Solaas K; van der Boom H; van Duyvenvoorde W; de Wit EC; Bloks VW; Kuipers F; Havekes LM; Princen HM J Cardiovasc Pharmacol; 2005 Jan; 45(1):53-60. PubMed ID: 15613980 [TBL] [Abstract][Full Text] [Related]
13. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice. Berthou L; Duverger N; Emmanuel F; Langouët S; Auwerx J; Guillouzo A; Fruchart JC; Rubin E; Denèfle P; Staels B; Branellec D J Clin Invest; 1996 Jun; 97(11):2408-16. PubMed ID: 8647932 [TBL] [Abstract][Full Text] [Related]
14. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of hypolipemic effects of lovastatin and gemfibrozil]. Gavelli MS; Vitaliano E; Rossi FG; Serra T; Santini G; Bernardi G Clin Ter; 1991 Jan; 136(1):31-8. PubMed ID: 1826871 [TBL] [Abstract][Full Text] [Related]
15. Modulation of plasma lipid levels affects benzo[a]pyrene-induced DNA damage in tissues of two hyperlipidemic mouse models. Curfs DM; Beckers L; Godschalk RW; Gijbels MJ; van Schooten FJ Environ Mol Mutagen; 2003; 42(4):243-9. PubMed ID: 14673869 [TBL] [Abstract][Full Text] [Related]
16. Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice. van Vlijmen BJ; Mensink RP; van 't Hof HB; Offermans RF; Hofker MH; Havekes LM J Lipid Res; 1998 Jun; 39(6):1181-8. PubMed ID: 9643349 [TBL] [Abstract][Full Text] [Related]
17. A case of moderate hypertriglyceridemia with apolipoprotein E phenotype E4/3. Kojima S; Homma Y; Sakane H; Kobayashi T; Ozawa H; Okajima Y Tokai J Exp Clin Med; 1996 Dec; 21(4-6):165-9. PubMed ID: 9300976 [TBL] [Abstract][Full Text] [Related]
18. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol. Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503 [TBL] [Abstract][Full Text] [Related]
19. The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076. Pearce NJ; Yates JW; Berkhout TA; Jackson B; Tew D; Boyd H; Camilleri P; Sweeney P; Gribble AD; Shaw A; Groot PH Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):113-9. PubMed ID: 9693110 [TBL] [Abstract][Full Text] [Related]
20. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment. Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]